Genetic structure of human A/H1N1 and A/H3N2 influenza virus on Corsica Island: phylogenetic analysis and vaccine strain match, 2006-2010.
Identifieur interne : 000385 ( Main/Exploration ); précédent : 000384; suivant : 000386Genetic structure of human A/H1N1 and A/H3N2 influenza virus on Corsica Island: phylogenetic analysis and vaccine strain match, 2006-2010.
Auteurs : Alessandra Falchi [France] ; Jean Pierre Amoros ; Christophe Arena ; Jean Arrighi ; François Casabianca ; Laurent Andreoletti ; Clément Turbelin ; Antoine Flahault ; Thierry Blanchon ; Thomas Hanslik ; Laurent VaresiSource :
- PloS one [ 1932-6203 ] ; 2011.
Descripteurs français
- KwdFr :
- France (épidémiologie), Grippe humaine (virologie), Grippe humaine (épidémiologie), Humains (MeSH), Phylogenèse (MeSH), Sous-type H1N1 du virus de la grippe A (classification), Sous-type H1N1 du virus de la grippe A (génétique), Sous-type H3N2 du virus de la grippe A (classification), Sous-type H3N2 du virus de la grippe A (génétique), Structures génétiques (génétique), Substitution d'acide aminé (génétique), Vaccins antigrippaux (génétique).
- MESH :
- génétique : Sous-type H1N1 du virus de la grippe A, Sous-type H3N2 du virus de la grippe A, Structures génétiques, Substitution d'acide aminé, Vaccins antigrippaux.
- virologie : Grippe humaine.
- épidémiologie : France, Grippe humaine.
- Humains, Phylogenèse.
- Wicri :
- geographic : France.
English descriptors
- KwdEn :
- Amino Acid Substitution (genetics), France (epidemiology), Genetic Structures (genetics), Humans (MeSH), Influenza A Virus, H1N1 Subtype (classification), Influenza A Virus, H1N1 Subtype (genetics), Influenza A Virus, H3N2 Subtype (classification), Influenza A Virus, H3N2 Subtype (genetics), Influenza Vaccines (genetics), Influenza, Human (epidemiology), Influenza, Human (virology), Phylogeny (MeSH).
- MESH :
- chemical , genetics : Influenza Vaccines.
- geographic , epidemiology : France.
- classification : Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype.
- epidemiology : Influenza, Human.
- genetics : Amino Acid Substitution, Genetic Structures, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype.
- virology : Influenza, Human.
- Humans, Phylogeny.
Abstract
BACKGROUND
The aim of this study was to analyse the genetic patterns of Hemagglutinin (HA) genes of influenza A strains circulating on Corsica Island during the 2006-2009 epidemic seasons and the 2009-2010 pandemic season.
METHODS
Nasopharyngeal samples from 371 patients with influenza-like illness (ILI) were collected by General Practitioners (GPs) of the Sentinelles Network through a randomised selection routine.
RESULTS
Phylogenetic analysis of HA revealed that A/H3N2 strains circulating on Corsica were closely related to the WHO recommended vaccine strains in each analyzed season (2006-2007 to 2008-2009). Seasonal Corsican influenza A/H1N1 isolated during the 2007-2008 season had drifted towards the A/Brisbane/59/2007 lineage, the A/H1N1 vaccine strain for the 2008-2009 season. The A/H1N1 2009 (A/H1N1pdm) strains isolated on Corsica Island were characterized by the S220T mutation specific to clade 7 isolates. It should be noted that Corsican isolates formed a separate sub-clade of clade 7 as a consequence of the presence of the fixed substitution D222E. The percentages of the perfect match vaccine efficacy, estimated by using the p(epitope) model, against influenza viruses circulating on Corsica Island varied substantially across the four seasons analyzed, and tend to be highest for A/H1N1 compared with A/H3N2 vaccines, suggesting that cross-immunity seems to be stronger for the H1 HA gene.
CONCLUSION
The molecular analysis of the HA gene of influenza viruses that circulated on Corsica Island between 2006-2010 showed for each season the presence of a dominant lineage characterized by at least one fixed mutation. The A/H3N2 and A/H1N1pdm isolates were characterized by multiples fixation at antigenic sites. The fixation of specific mutations at each outbreak could be explained by the combination of a neutral phenomenon and a founder effect, favoring the presence of a dominant lineage in a closed environment such as Corsica Island.
DOI: 10.1371/journal.pone.0024471
PubMed: 21935413
PubMed Central: PMC3173375
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Genetic structure of human A/H1N1 and A/H3N2 influenza virus on Corsica Island: phylogenetic analysis and vaccine strain match, 2006-2010.</title><author><name sortKey="Falchi, Alessandra" sort="Falchi, Alessandra" uniqKey="Falchi A" first="Alessandra" last="Falchi">Alessandra Falchi</name><affiliation wicri:level="3"><nlm:affiliation>INSERM, UMR-S 707, F-75012, Paris, France. falchi@u707.jussieu.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM, UMR-S 707, F-75012, Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Amoros, Jean Pierre" sort="Amoros, Jean Pierre" uniqKey="Amoros J" first="Jean Pierre" last="Amoros">Jean Pierre Amoros</name></author><author><name sortKey="Arena, Christophe" sort="Arena, Christophe" uniqKey="Arena C" first="Christophe" last="Arena">Christophe Arena</name></author><author><name sortKey="Arrighi, Jean" sort="Arrighi, Jean" uniqKey="Arrighi J" first="Jean" last="Arrighi">Jean Arrighi</name></author><author><name sortKey="Casabianca, Francois" sort="Casabianca, Francois" uniqKey="Casabianca F" first="François" last="Casabianca">François Casabianca</name></author><author><name sortKey="Andreoletti, Laurent" sort="Andreoletti, Laurent" uniqKey="Andreoletti L" first="Laurent" last="Andreoletti">Laurent Andreoletti</name></author><author><name sortKey="Turbelin, Clement" sort="Turbelin, Clement" uniqKey="Turbelin C" first="Clément" last="Turbelin">Clément Turbelin</name></author><author><name sortKey="Flahault, Antoine" sort="Flahault, Antoine" uniqKey="Flahault A" first="Antoine" last="Flahault">Antoine Flahault</name></author><author><name sortKey="Blanchon, Thierry" sort="Blanchon, Thierry" uniqKey="Blanchon T" first="Thierry" last="Blanchon">Thierry Blanchon</name></author><author><name sortKey="Hanslik, Thomas" sort="Hanslik, Thomas" uniqKey="Hanslik T" first="Thomas" last="Hanslik">Thomas Hanslik</name></author><author><name sortKey="Varesi, Laurent" sort="Varesi, Laurent" uniqKey="Varesi L" first="Laurent" last="Varesi">Laurent Varesi</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21935413</idno><idno type="pmid">21935413</idno><idno type="doi">10.1371/journal.pone.0024471</idno><idno type="pmc">PMC3173375</idno><idno type="wicri:Area/Main/Corpus">000352</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000352</idno><idno type="wicri:Area/Main/Curation">000352</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000352</idno><idno type="wicri:Area/Main/Exploration">000352</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Genetic structure of human A/H1N1 and A/H3N2 influenza virus on Corsica Island: phylogenetic analysis and vaccine strain match, 2006-2010.</title><author><name sortKey="Falchi, Alessandra" sort="Falchi, Alessandra" uniqKey="Falchi A" first="Alessandra" last="Falchi">Alessandra Falchi</name><affiliation wicri:level="3"><nlm:affiliation>INSERM, UMR-S 707, F-75012, Paris, France. falchi@u707.jussieu.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM, UMR-S 707, F-75012, Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Amoros, Jean Pierre" sort="Amoros, Jean Pierre" uniqKey="Amoros J" first="Jean Pierre" last="Amoros">Jean Pierre Amoros</name></author><author><name sortKey="Arena, Christophe" sort="Arena, Christophe" uniqKey="Arena C" first="Christophe" last="Arena">Christophe Arena</name></author><author><name sortKey="Arrighi, Jean" sort="Arrighi, Jean" uniqKey="Arrighi J" first="Jean" last="Arrighi">Jean Arrighi</name></author><author><name sortKey="Casabianca, Francois" sort="Casabianca, Francois" uniqKey="Casabianca F" first="François" last="Casabianca">François Casabianca</name></author><author><name sortKey="Andreoletti, Laurent" sort="Andreoletti, Laurent" uniqKey="Andreoletti L" first="Laurent" last="Andreoletti">Laurent Andreoletti</name></author><author><name sortKey="Turbelin, Clement" sort="Turbelin, Clement" uniqKey="Turbelin C" first="Clément" last="Turbelin">Clément Turbelin</name></author><author><name sortKey="Flahault, Antoine" sort="Flahault, Antoine" uniqKey="Flahault A" first="Antoine" last="Flahault">Antoine Flahault</name></author><author><name sortKey="Blanchon, Thierry" sort="Blanchon, Thierry" uniqKey="Blanchon T" first="Thierry" last="Blanchon">Thierry Blanchon</name></author><author><name sortKey="Hanslik, Thomas" sort="Hanslik, Thomas" uniqKey="Hanslik T" first="Thomas" last="Hanslik">Thomas Hanslik</name></author><author><name sortKey="Varesi, Laurent" sort="Varesi, Laurent" uniqKey="Varesi L" first="Laurent" last="Varesi">Laurent Varesi</name></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Substitution (genetics)</term><term>France (epidemiology)</term><term>Genetic Structures (genetics)</term><term>Humans (MeSH)</term><term>Influenza A Virus, H1N1 Subtype (classification)</term><term>Influenza A Virus, H1N1 Subtype (genetics)</term><term>Influenza A Virus, H3N2 Subtype (classification)</term><term>Influenza A Virus, H3N2 Subtype (genetics)</term><term>Influenza Vaccines (genetics)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (virology)</term><term>Phylogeny (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>France (épidémiologie)</term><term>Grippe humaine (virologie)</term><term>Grippe humaine (épidémiologie)</term><term>Humains (MeSH)</term><term>Phylogenèse (MeSH)</term><term>Sous-type H1N1 du virus de la grippe A (classification)</term><term>Sous-type H1N1 du virus de la grippe A (génétique)</term><term>Sous-type H3N2 du virus de la grippe A (classification)</term><term>Sous-type H3N2 du virus de la grippe A (génétique)</term><term>Structures génétiques (génétique)</term><term>Substitution d'acide aminé (génétique)</term><term>Vaccins antigrippaux (génétique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>France</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza A Virus, H3N2 Subtype</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Amino Acid Substitution</term><term>Genetic Structures</term><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza A Virus, H3N2 Subtype</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term><term>Sous-type H3N2 du virus de la grippe A</term><term>Structures génétiques</term><term>Substitution d'acide aminé</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>France</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Phylogeny</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Phylogenèse</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>The aim of this study was to analyse the genetic patterns of Hemagglutinin (HA) genes of influenza A strains circulating on Corsica Island during the 2006-2009 epidemic seasons and the 2009-2010 pandemic season.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Nasopharyngeal samples from 371 patients with influenza-like illness (ILI) were collected by General Practitioners (GPs) of the Sentinelles Network through a randomised selection routine.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Phylogenetic analysis of HA revealed that A/H3N2 strains circulating on Corsica were closely related to the WHO recommended vaccine strains in each analyzed season (2006-2007 to 2008-2009). Seasonal Corsican influenza A/H1N1 isolated during the 2007-2008 season had drifted towards the A/Brisbane/59/2007 lineage, the A/H1N1 vaccine strain for the 2008-2009 season. The A/H1N1 2009 (A/H1N1pdm) strains isolated on Corsica Island were characterized by the S220T mutation specific to clade 7 isolates. It should be noted that Corsican isolates formed a separate sub-clade of clade 7 as a consequence of the presence of the fixed substitution D222E. The percentages of the perfect match vaccine efficacy, estimated by using the p(epitope) model, against influenza viruses circulating on Corsica Island varied substantially across the four seasons analyzed, and tend to be highest for A/H1N1 compared with A/H3N2 vaccines, suggesting that cross-immunity seems to be stronger for the H1 HA gene.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>The molecular analysis of the HA gene of influenza viruses that circulated on Corsica Island between 2006-2010 showed for each season the presence of a dominant lineage characterized by at least one fixed mutation. The A/H3N2 and A/H1N1pdm isolates were characterized by multiples fixation at antigenic sites. The fixation of specific mutations at each outbreak could be explained by the combination of a neutral phenomenon and a founder effect, favoring the presence of a dominant lineage in a closed environment such as Corsica Island.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21935413</PMID><DateCompleted><Year>2012</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>9</Issue><PubDate><Year>2011</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Genetic structure of human A/H1N1 and A/H3N2 influenza virus on Corsica Island: phylogenetic analysis and vaccine strain match, 2006-2010.</ArticleTitle><Pagination><MedlinePgn>e24471</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0024471</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The aim of this study was to analyse the genetic patterns of Hemagglutinin (HA) genes of influenza A strains circulating on Corsica Island during the 2006-2009 epidemic seasons and the 2009-2010 pandemic season.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Nasopharyngeal samples from 371 patients with influenza-like illness (ILI) were collected by General Practitioners (GPs) of the Sentinelles Network through a randomised selection routine.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Phylogenetic analysis of HA revealed that A/H3N2 strains circulating on Corsica were closely related to the WHO recommended vaccine strains in each analyzed season (2006-2007 to 2008-2009). Seasonal Corsican influenza A/H1N1 isolated during the 2007-2008 season had drifted towards the A/Brisbane/59/2007 lineage, the A/H1N1 vaccine strain for the 2008-2009 season. The A/H1N1 2009 (A/H1N1pdm) strains isolated on Corsica Island were characterized by the S220T mutation specific to clade 7 isolates. It should be noted that Corsican isolates formed a separate sub-clade of clade 7 as a consequence of the presence of the fixed substitution D222E. The percentages of the perfect match vaccine efficacy, estimated by using the p(epitope) model, against influenza viruses circulating on Corsica Island varied substantially across the four seasons analyzed, and tend to be highest for A/H1N1 compared with A/H3N2 vaccines, suggesting that cross-immunity seems to be stronger for the H1 HA gene.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The molecular analysis of the HA gene of influenza viruses that circulated on Corsica Island between 2006-2010 showed for each season the presence of a dominant lineage characterized by at least one fixed mutation. The A/H3N2 and A/H1N1pdm isolates were characterized by multiples fixation at antigenic sites. The fixation of specific mutations at each outbreak could be explained by the combination of a neutral phenomenon and a founder effect, favoring the presence of a dominant lineage in a closed environment such as Corsica Island.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Falchi</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>INSERM, UMR-S 707, F-75012, Paris, France. falchi@u707.jussieu.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amoros</LastName><ForeName>Jean Pierre</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Arena</LastName><ForeName>Christophe</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Arrighi</LastName><ForeName>Jean</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Casabianca</LastName><ForeName>François</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Andreoletti</LastName><ForeName>Laurent</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Turbelin</LastName><ForeName>Clément</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Flahault</LastName><ForeName>Antoine</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Blanchon</LastName><ForeName>Thierry</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Hanslik</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Varesi</LastName><ForeName>Laurent</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040342" MajorTopicYN="N">Genetic Structures</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053122" MajorTopicYN="N">Influenza A Virus, H3N2 Subtype</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>04</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>08</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21935413</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0024471</ArticleId><ArticleId IdType="pii">PONE-D-11-07419</ArticleId><ArticleId IdType="pmc">PMC3173375</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Virol J. 2010;7:297</Citation><ArticleIdList><ArticleId IdType="pubmed">21040570</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2009 Jul;45(3):265-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19502107</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbiol Rev. 1992 Mar;56(1):152-79</Citation><ArticleIdList><ArticleId IdType="pubmed">1579108</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Curr. 2009 Nov 03;1:RRN1126</Citation><ArticleIdList><ArticleId IdType="pubmed">20029664</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Immunol. 1990;8:737-71</Citation><ArticleIdList><ArticleId IdType="pubmed">2188678</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2011;12 Suppl 1:S31</Citation><ArticleIdList><ArticleId IdType="pubmed">21342562</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Virol. 1996;141(7):1349-55</Citation><ArticleIdList><ArticleId IdType="pubmed">8774693</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2000 Apr;38(4):1552-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10747142</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 1995 May;33(5):1180-4</Citation><ArticleIdList><ArticleId IdType="pubmed">7615726</ArticleId></ArticleIdList></Reference><Reference><Citation>Protein Eng Des Sel. 2011 Mar;24(3):291-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21123189</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1999 Dec 3;286(5446):1921-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10583948</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene. 2008 Dec 31;427(1-2):111-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18848975</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2006 May 1;24(18):3881-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16460844</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Evol. 2008 Sep;25(9):1809-24</Citation><ArticleIdList><ArticleId IdType="pubmed">18511426</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Rev Lett. 2003 Aug 8;91(6):068101</Citation><ArticleIdList><ArticleId IdType="pubmed">12935112</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2009 May 1;58(16):431-3</Citation><ArticleIdList><ArticleId IdType="pubmed">19407737</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 2006 Nov 20;185(10 Suppl):S39-43</Citation><ArticleIdList><ArticleId IdType="pubmed">17115950</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Evol. 2011 Sep;28(9):2443-51</Citation><ArticleIdList><ArticleId IdType="pubmed">21415025</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect. 2000 May;40(3):218-28</Citation><ArticleIdList><ArticleId IdType="pubmed">10908015</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1997 Dec 15;25(24):4876-82</Citation><ArticleIdList><ArticleId IdType="pubmed">9396791</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol Methods. 2007 Jan;139(1):90-2</Citation><ArticleIdList><ArticleId IdType="pubmed">17030067</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Mar 27;422(6930):428-33</Citation><ArticleIdList><ArticleId IdType="pubmed">12660783</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Infect. 2010 Apr;16(4):317-21</Citation><ArticleIdList><ArticleId IdType="pubmed">20121827</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Genet Evol. 2011 Jul;11(5):997-1005</Citation><ArticleIdList><ArticleId IdType="pubmed">21457796</ArticleId></ArticleIdList></Reference><Reference><Citation>Protein Eng Des Sel. 2009 Sep;22(9):543-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19578121</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6283-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17395716</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1980 Dec;112(6):814-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7457472</ArticleId></ArticleIdList></Reference><Reference><Citation>Syst Biol. 2003 Oct;52(5):696-704</Citation><ArticleIdList><ArticleId IdType="pubmed">14530136</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2010 Sep 30;405(2):314-21</Citation><ArticleIdList><ArticleId IdType="pubmed">20598336</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10748-52</Citation><ArticleIdList><ArticleId IdType="pubmed">12136133</ArticleId></ArticleIdList></Reference><Reference><Citation>Virol J. 2011;8:183</Citation><ArticleIdList><ArticleId IdType="pubmed">21507270</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2009 Jun 25;459(7250):1122-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19516283</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010;15(43). pii: 19696</Citation><ArticleIdList><ArticleId IdType="pubmed">21087581</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2008 May 29;453(7195):615-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18418375</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2006 Apr 21;312(5772):404-10</Citation><ArticleIdList><ArticleId IdType="pubmed">16543414</ArticleId></ArticleIdList></Reference><Reference><Citation>Syst Biol. 2001 Aug;50(4):580-601</Citation><ArticleIdList><ArticleId IdType="pubmed">12116655</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Evol. 2007 Aug;24(8):1596-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17488738</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010 Mar 4;15(9). pii: 19498</Citation><ArticleIdList><ArticleId IdType="pubmed">20214869</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 1986 Nov;76(11):1289-92</Citation><ArticleIdList><ArticleId IdType="pubmed">3766824</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 2004 Jul;103(1-2):47-52</Citation><ArticleIdList><ArticleId IdType="pubmed">15163487</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010;5(3):e9717</Citation><ArticleIdList><ArticleId IdType="pubmed">20300536</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Paris</li></settlement></list><tree><noCountry><name sortKey="Amoros, Jean Pierre" sort="Amoros, Jean Pierre" uniqKey="Amoros J" first="Jean Pierre" last="Amoros">Jean Pierre Amoros</name><name sortKey="Andreoletti, Laurent" sort="Andreoletti, Laurent" uniqKey="Andreoletti L" first="Laurent" last="Andreoletti">Laurent Andreoletti</name><name sortKey="Arena, Christophe" sort="Arena, Christophe" uniqKey="Arena C" first="Christophe" last="Arena">Christophe Arena</name><name sortKey="Arrighi, Jean" sort="Arrighi, Jean" uniqKey="Arrighi J" first="Jean" last="Arrighi">Jean Arrighi</name><name sortKey="Blanchon, Thierry" sort="Blanchon, Thierry" uniqKey="Blanchon T" first="Thierry" last="Blanchon">Thierry Blanchon</name><name sortKey="Casabianca, Francois" sort="Casabianca, Francois" uniqKey="Casabianca F" first="François" last="Casabianca">François Casabianca</name><name sortKey="Flahault, Antoine" sort="Flahault, Antoine" uniqKey="Flahault A" first="Antoine" last="Flahault">Antoine Flahault</name><name sortKey="Hanslik, Thomas" sort="Hanslik, Thomas" uniqKey="Hanslik T" first="Thomas" last="Hanslik">Thomas Hanslik</name><name sortKey="Turbelin, Clement" sort="Turbelin, Clement" uniqKey="Turbelin C" first="Clément" last="Turbelin">Clément Turbelin</name><name sortKey="Varesi, Laurent" sort="Varesi, Laurent" uniqKey="Varesi L" first="Laurent" last="Varesi">Laurent Varesi</name></noCountry><country name="France"><region name="Île-de-France"><name sortKey="Falchi, Alessandra" sort="Falchi, Alessandra" uniqKey="Falchi A" first="Alessandra" last="Falchi">Alessandra Falchi</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000385 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000385 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21935413
|texte= Genetic structure of human A/H1N1 and A/H3N2 influenza virus on Corsica Island: phylogenetic analysis and vaccine strain match, 2006-2010.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21935413" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeFranceV1
| This area was generated with Dilib version V0.6.35. |  |